Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis

被引:10
|
作者
Wybrecht, Delphine [1 ,2 ]
Reuter, Francoise [1 ,3 ]
Zaaraoui, Wafaa [1 ]
Faivre, Anthony [1 ,2 ]
Crespy, Lydie [1 ,3 ]
Rico, Audrey [1 ,3 ]
Malikova, Irina [1 ,3 ]
Confort-Gouny, Sylviane [1 ]
Soulier, Elisabeth [1 ]
Cozzone, Patrick J. [1 ]
Pelletier, Jean [1 ,3 ]
Ranjeva, Jean-Philippe [1 ]
Audoin, Bertrand [1 ,3 ]
机构
[1] Aix Marseille Univ, CEMEREM, UMR 7339, Marseille, France
[2] Hop Instruct Armees St Anne, Serv Neurol, F-83800 Toulon, France
[3] Hop Enfants La Timone, APHM, Serv Neurol, Marseille, France
关键词
multiple sclerosis; MRI; cognition; disability; prediction; CIS; CLINICALLY ISOLATED SYNDROMES; EARLY COGNITIVE IMPAIRMENT; 10-YEAR FOLLOW-UP; LESION LOCATION; CALLOSAL ATROPHY; BRAIN MRI; ABNORMALITIES; DEFICITS; ONSET;
D O I
10.1177/1352458512442991
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The ability of conventional magnetic resonance imaging (MRI) to predict subsequent physical disability and cognitive deterioration after a clinically isolated syndrome (CIS) is weak. Objectives: We aimed to investigate whether conventional MRI changes over 1 year could predict cognitive and physical disability 5 years later in CIS. We performed analyses using a global approach (T-2 lesion load, number of T-2 lesions), but also a topographic approach. Methods: This study included 38 patients with a CIS. At inclusion, 10 out of 38 patients fulfilled the 2010 revised McDonald's criteria for the diagnosis of multiple sclerosis. Expanded Disability Status Scale (EDSS) evaluation was performed at baseline, year 1 and year 5, and cognitive evaluation at baseline and year 5.T-2-weighted MRI was performed at baseline and year 1. We used voxelwise analysis to analyse the predictive value of lesions location for subsequent disability. Results: Using the global approach, no correlation was found between MRI and clinical data. The occurrence or growth of new lesions in the brainstem was correlated with EDSS changes over the 5 years of follow-up. The occurrence or growth of new lesions in cerebellum, thalami, corpus callosum and frontal lobes over 1 year was correlated with cognitive impairment at 5 years. Conclusion: The assessment of lesion location at the first stage of multiple sclerosis may be of value to predict future clinical disability.
引用
收藏
页码:1585 / 1591
页数:7
相关论文
共 50 条
  • [1] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [2] Sexual dysfunction in relapsing-remitting multiple sclerosis: Magnetic resonance imaging, clinical, and psychological correlates
    Barak, Y
    Achiron, A
    Elizur, A
    Gabbay, U
    Noy, S
    SarovaPinhas, I
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1996, 21 (04): : 255 - 258
  • [3] Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing-Remitting Multiple Sclerosis
    Grahl, S.
    Bussas, M.
    Wiestler, B.
    Eichinger, P.
    Gaser, C.
    Kirschke, J.
    Zimmer, C.
    Berthele, A.
    Hemmer, B.
    Muehlau, M.
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2589 - 2597
  • [4] Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis
    Wauschkuhn, Josephine
    Buenrostro, Gilberto Solorza
    Aly, Lilian
    Asseyer, Susanna
    Wicklein, Rebecca
    Hartberger, Julia Maria
    Ruprecht, Klemens
    Muehlau, Mark
    Schmitz-Huebsch, Tanja
    Chien, Claudia
    Berthele, Achim
    Brandt, Alexander U. U.
    Korn, Thomas
    Paul, Friedemann
    Hemmer, Bernhard
    Zimmermann, Hanna G. G.
    Knier, Benjamin
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (04) : 982 - 990
  • [5] Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 22 - 27
  • [6] Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
    Cocco, E.
    Marchi, P.
    Sardu, C.
    Russo, P.
    Paolillo, A.
    Mascia, M. G.
    Solla, M.
    Frau, J.
    Lorefice, L.
    Massole, S.
    Floris, G.
    Marrosu, M. G.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (08) : 975 - 980
  • [7] Cognitive deficits in early relapsing-remitting multiple sclerosis
    Tinnefeld, M.
    Wilhelm, H.
    Daum, I.
    Faustmann, P. M.
    Haase, C. G.
    AKTUELLE NEUROLOGIE, 2008, 35 (01) : 2 - 7
  • [8] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [9] Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study
    De Stefano, N
    Matthews, PM
    Fu, LQ
    Narayanan, S
    Stanley, J
    Francis, GS
    Antel, JP
    Arnold, DL
    BRAIN, 1998, 121 : 1469 - 1477
  • [10] Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    Rotstein, Z
    MULTIPLE SCLEROSIS, 2003, 9 (05): : 486 - 491